Evidence map›Paper›PMID 38585266›Full record

ArticleFrontiers in immunology2024

The neutralizing effect of heparin on blood-derived antimicrobial compounds: impact on antibacterial activity and inflammatory response.

Denisa Cont, Stephan Harm, Claudia Schildböck, Claudia Kolm, Alexander K T Kirschner, Andreas H Farnleitner, Matthias Pilecky, Jennifer Zottl, Jens Hartmann, Viktoria Weber

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Dextran sulfate restores endotoxin detectability in human serum.Analytical and bioanalytical chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Denisa ContDepartment for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Stephan HarmDepartment for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Claudia SchildböckDepartment for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Claudia KolmDepartment of Physiology, Pharmacology and Microbiology, Division Water Quality and Health, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
Alexander K T KirschnerDepartment of Physiology, Pharmacology and Microbiology, Division Water Quality and Health, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
Andreas H FarnleitnerDepartment of Physiology, Pharmacology and Microbiology, Division Water Quality and Health, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
Matthias PileckyResearch Lab Aquatic Ecosystem Research and Health, University for Continuing Education Krems, Krems an der Donau, Austria.
Jennifer ZottlDepartment for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Jens Hartmann *Department for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Viktoria Weber *Department for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Universität für Weiterbildung Krems · ATKarl Landsteiner University of Health Sciences · ATMedical University of Vienna · ATTU Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acting through a combination of direct and indirect pathogen clearance mechanisms, blood-derived antimicrobial compounds (AMCs) play a pivotal role in innate immunity, safeguarding the host against invading microorganisms. Besides their antimicrobial activity, some AMCs can neutralize endotoxins, preventing their interaction with immune cells and avoiding an excessive inflammatory response. In this study, we aimed to investigate the influence of unfractionated heparin, a polyanionic drug clinically used as anticoagulant, on the endotoxin-neutralizing and antibacterial activity of blood-derived AMCs. Serum samples from healthy donors were pre-incubated with increasing concentrations of heparin for different time periods and tested against pathogenic bacteria (

Indexed as

Anti-Infective AgentsHeparinAnti-Bacterial AgentsEndotoxinsEscherichia coliKlebsiella pneumoniaeAnti-Bacterial AgentsAnti-Infective AgentsEndotoxinsHeparinantibacterial activityantimicrobial compoundsendotoxin neutralizationheparinhost defense peptidesLPSpathogenic bacteria

Identifiers

PMID38585266
PMCPMC10995223
OpenAlexW4393092122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.